Sign Up to like & get
recommendations!
0
Published in 2021 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359211010939
Abstract: Background: China’s Fujian Cervical Pilot Project (FCPP) transitioned cervical cancer screening from high-risk human papillomavirus (HR-HPV) nongenotyping to genotyping. We investigated the clinical impact of this introduction, comparing performance indicators between HR-HPV genotyping combined with…
read more here.
Keywords:
hpv genotyping;
cervical cancer;
period;
hpv nongenotyping ... See more keywords